We are live on ! Find out more
PCVX icon

Vaxcyte
PCVX

251 hedge funds and large institutions have $8.13B invested in Vaxcyte in 2024 Q1 according to their latest regulatory filings, with 48 funds opening new positions, 102 increasing their positions, 77 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 48 | Existing positions closed: 18

37% more call options, than puts

Call options by funds: $16.7M | Put options by funds: $12.2M

32% more repeat investments, than reductions

Existing positions increased: 102 | Existing positions reduced: 77

25% more capital invested

Capital invested by funds: $6.51B → $8.13B (+$1.63B)

13% more funds holding

Funds holding: 223 → 251 (+28)

0.97% more ownership

Funds ownership: 108.91% → 109.87% (+0.97%)

14% less funds holding in top 10

Funds holding in top 10: 14 → 12 (-2)

Holders
251
Holders Change
+28
Holders Change %
+12.56%
% of All Funds
3.62%
Holding in Top 10
12
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-14.29%
% of All Funds
0.17%
New
48
Increased
102
Reduced
77
Closed
18
Calls
$16.7M
Puts
$12.2M
Net Calls
+$4.53M
Net Calls Change
-$2.42M

Top Buyers

1
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
+$160M
2
DGM
Darwin Global Management
Jersey
+$150M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$142M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$89M
5
PBA
Paradigm Biocapital Advisors
New York
+$85.9M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$40.5M
2
Millennium Management
Millennium Management
New York
-$33.5M
3
VPC
Vestal Point Capital
New York
-$33M
4
GPP
Great Point Partners
Connecticut
-$22.6M
5
Pictet Asset Management
Pictet Asset Management
Switzerland
-$19.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
BPC
101
Banque Pictet & Cie
Switzerland
$4.16M +$4.22M +60,887 New
State of Wisconsin Investment Board
102
State of Wisconsin Investment Board
Wisconsin
$4.14M +$241K +3,485 +6%
FLAM
103
First Light Asset Management
Minnesota
$4.12M +$4.17M +60,284 New
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
104
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$4.06M +$4.11M +59,400 New
Prudential Financial
105
Prudential Financial
New Jersey
$3.75M +$1.27M +18,330 +50%
New York State Common Retirement Fund
106
New York State Common Retirement Fund
New York
$3.7M -$32.4K -468 -0.9%
MIM
107
MetLife Investment Management
New Jersey
$3.69M +$327K +4,726 +10%
State of New Jersey Common Pension Fund D
108
State of New Jersey Common Pension Fund D
New Jersey
$3.65M +$350K +5,048 +10%
AIG
109
American International Group
New York
$3.57M +$394K +5,686 +12%
SSA
110
Schonfeld Strategic Advisors
New York
$3.52M -$5.66M -81,688 -61%
BBA
111
Baker Bros. Advisors
New York
$3.34M – – –
Dimensional Fund Advisors
112
Dimensional Fund Advisors
Texas
$3.25M +$905K +13,068 +38%
Allspring Global Investments
113
Allspring Global Investments
North Carolina
$3.24M +$1.72M +24,785 +110%
Connor, Clark & Lunn Investment Management (CC&L)
114
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$3.13M +$3.17M +45,766 New
MOACM
115
Mutual of America Capital Management
New York
$3.05M -$251K -3,631 -8%
Susquehanna International Group
116
Susquehanna International Group
Pennsylvania
$2.99M +$908K +13,113 +43%
EI
117
EAM Investors
California
$2.99M +$3.03M +43,732 New
Wells Fargo
118
Wells Fargo
California
$2.94M +$501K +7,242 +20%
Envestnet Asset Management
119
Envestnet Asset Management
Illinois
$2.92M -$427K -6,169 -13%
ACH
120
ArrowMark Colorado Holdings
Colorado
$2.73M +$2.77M +40,000 New
BBHC
121
Brown Brothers Harriman & Co
New York
$2.6M – – –
EAM
122
Erste Asset Management
Austria
$2.3M – – –
TC
123
TwinBeech Capital
New York
$2.16M +$2.19M +31,647 New
GC
124
Guggenheim Capital
Illinois
$2.15M +$271K +3,915 +14%
JF
125
Jump Financial
Illinois
$2.06M +$2.09M +30,224 New
3 4
5
6 7

PCVX Hedge Fund Activity: Q1 2024 in Review

251 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Vaxcyte (PCVX) for Q1 2024, worth a combined $8.13B — up 25% from $6.51B a quarter earlier.

Buyers outnumbered sellers: 48 funds opened new PCVX positions and 18 closed out — a net gain of 30 holders — while 102 added to existing stakes and 77 trimmed.

The largest buyer was T. Rowe Price Investment Management, adding an estimated $160M. The largest seller was Morgan Stanley, cutting an estimated $40.5M.

  • 251 institutional investors held Vaxcyte (PCVX) as of Q1 2024, up from 223 in Q4 2023.
  • Funds reported $8.13B of Vaxcyte stock for Q1 2024, up 25% quarter-over-quarter.
  • 48 funds opened new Vaxcyte positions in Q1 2024 and 18 closed out, a net change of +30 holders.
  • The largest Vaxcyte buyer in Q1 2024 was T. Rowe Price Investment Management, an estimated $160M added.
  • The largest Vaxcyte seller in Q1 2024 was Morgan Stanley, an estimated $40.5M sold.

Based on aggregated 13F filings for Q1 2024.